What is AMRN stock price today?

AMRN (Amarin Corp Plc) stock is trading at $13.93 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is AMRN stock going up or down today?

AMRN stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy AMRN stock now?

The decision to buy AMRN depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is AMRN a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for AMRN based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is AMRN stock overvalued or undervalued?

Use our DCF valuation calculator to determine if AMRN is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is AMRN's P/E ratio?

P/E ratio data for AMRN will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is AMRN's market cap?

AMRN (Amarin Corp Plc) has a market capitalization of $0.29 billion, making it a small-cap stock.

What is AMRN's price to book ratio?

AMRN trades at a price-to-book (P/B) ratio of 0.63, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does AMRN pay dividends?

AMRN does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is AMRN's dividend yield?

AMRN does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is AMRN stock a good long-term investment?

AMRN's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is AMRN's revenue growth rate?

AMRN has shown revenue growth of -0.2% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

AMRN is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in AMRN?

Key risks for AMRN include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does AMRN compare to its competitors?

Compare AMRN to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize AMRN's performance and positioning.

What is AMRN's stock price target for 2026?

Our AI model provides price targets for AMRN based on fundamental analysis: Bull case $18.11 (+30%), Base case $16.02 (+15%), Bear case $12.54 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about AMRN?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for AMRN. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is AMRN's next earnings report?

AMRN reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

AMRN - Amarin Corp Plc

NYSE * Health Care * Pharmaceuticals

$13.93

+$0.13 (+0.94%)

About Amarin Corp Plc

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

AMRN Key Statistics

Market Cap

$289.64M

P/B Ratio

0.63

EPS

$-4.20

Revenue Growth

-0.2%

Profit Margin

-0.2%

Employees

275

How AMRN Compares to Peers

AMRN is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 1

Margin Rank

of 2

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
AMRN(This stock)	$289.64M	N/A	-0%	-0.2%	-
AMZNAmazon Com	$2.35T	30.2	0%	0.1%	vs AMZN

Amarin Corp Plc Company Information

Headquarters: Ireland
Website: www.amarincorp.com
Sector: Health Care
Industry: Pharmaceuticals

AMRN - Amarin Corp Plc

About Amarin Corp Plc

AMRN Key Statistics

How AMRN Compares to Peers

Amarin Corp Plc Company Information

AMRN Lician Score

AMRN Financial Snowflake

Upcoming Events for AMRN